Загрузка...
Docetaxel and Mitoxantrone Prior to Radical Prostatectomy in Men with High Risk Prostate Cancer: Ten-Year Follow Up and Immune Correlates
OBJECTIVES. To report the clinical outcomes a cohort of men with high-risk prostate cancer treated with neoadjuvant docetaxel and mitoxantrone ten years after treatment. To identify pretreatment clinical parameters that maybe predictors of recurrence, and to describe tumor infiltrating leukocytes pr...
Сохранить в:
| Опубликовано в: : | Anticancer Drugs |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7370800/ https://ncbi.nlm.nih.gov/pubmed/27669423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000438 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|